Ocuphire Pharma, Inc. (OCUP) Tops Q3 EPS by 47c

Ocuphire Pharma, Inc. (NASDAQ: OCUP) reported Q3 EPS of $0.25, $0.47 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $3.03 million.

For earnings history and earnings-related data on Ocuphire Pharma, Inc. (OCUP) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Bit Digital (BTBT) Misses Q2 EPS by 27c